Form Of INDEMNIFICATION AGREEMENTIndemnification Agreement • November 6th, 2023 • Sequoia Vaccines, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of _______, 2023 between Sequoia Vaccines, Inc., a Delaware corporation (the “Company”), and _____________________________________ (“Indemnitee”).
SEQUOIA VACCINES, INC. 2021 INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • November 6th, 2023 • Sequoia Vaccines, Inc. • Biological products, (no disgnostic substances) • Missouri
THIS 2021 INVESTORS’ RIGHTS AGREEMENT (“Agreement”) is made as of ____April 30__, 2021 by and among Sequoia Vaccines, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A (each of which is referred to in this Agreement as an “Investor”), and any additional investor that becomes a party to this Agreement in accordance with Section 6.9 hereof. This Agreement supersedes and replaces in its entirety that 2020 Amended and Restated Investors’ Rights Agreement dated April 6, 2020 by and among the Company and the other parties thereto.
NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • November 6th, 2023 • Sequoia Vaccines, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS NON-QUALIFIED STOCK OPTION AGREEMENT, effective as of [DATE OF AGREEMENT], is made between Sequoia Vaccines, Inc. (the “Company”), a Delaware corporation, and [NAME OF OPTIONEE] (the “Optionee”), a [consultant/advisor/employee/director] to the Company.
PLAN OF MERGER AND COMBINATION AGREEMENTPlan of Merger and Combination Agreement • November 6th, 2023 • Sequoia Vaccines, Inc. • Biological products, (no disgnostic substances) • Missouri
THIS PLAN OF MERGER AND COMBINATION AGREEMENT (“Agreement”) is made and entered into effective as of April 22, 2021 (the “Effective Date”) by and among Sequoia Vaccines, Inc., a Delaware corporation (“Vaccines”), Sequoia Sciences UTI, LLC, a Delaware limited liability company (“UTI”), and Sequoia Sciences, Inc., a Delaware corporation (“Sciences”, and collectively, the “Parties” and each a “Party”). In consideration of the mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows.
INTERNATIONAL COLLECTING AGREEMENTInternational Collecting Agreement • November 6th, 2023 • Sequoia Vaccines, Inc. • Biological products, (no disgnostic substances)
This International Collecting Agreement (“Agreement”) is made and entered into on the later date signed below, by and among the Institut de la Pharmacopée et de Médecine Traditionnelles of the Centre National de la Recherche Scientifique et Technologique, a research institution of the Gabonese Republic (“IPHAMETRA-CENAREST”), MISSOURI BOTANICAL GARDEN, a Missouri Charitable trust (“MBG”), and SEQUOIA SCIENCES, INC., a California Corporation (“Sequoia”).
RESTRICTED STOCK GRANT AGREEMENTRestricted Stock Grant Agreement • November 6th, 2023 • Sequoia Vaccines, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT is effective as of [DATE OF AGREEMENT], by and between Sequoia Vaccines, Inc. (the “Company), a Delaware corporation, and [NAME OF GRANTEE] (the “Grantee”), a [consultant/advisor/employee/director] to the Company.
INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • November 6th, 2023 • Sequoia Vaccines, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS INCENTIVE STOCK OPTION AGREEMENT, effective as of [DATE OF AGREEMENT], is made between Sequoia Vaccines, Inc. (the “Company”), a Delaware corporation, and [NAME OF EMPLOYEE] (the “Employee”), an employee of the Company.
